ArticleFrontiers in oncology2019

Multi-antigen Vaccination With Simultaneous Engagement of the OX40 Receptor Delays Malignant Mesothelioma Growth and Increases Survival in Animal Models.

Peter R Hoffmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.